Braver Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
BIT
BFA
Braver Wealth Management's AMGN Position: Q4 2016 in Review
Braver Wealth Management increased its Amgen (AMGN) stake by 0.35% in Q4 2016, buying an estimated $12.6K and bringing the position to 23,908 shares worth $3.5M. The position accounts for 0.57% of the portfolio, ranked #53.
Braver Wealth Management first reported a position in AMGN in Q1 2014 and has held it in 12 quarters since. The position peaked at $4.83M in Q1 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.
- Braver Wealth Management held 23,908 shares of Amgen worth $3.5M as of Q4 2016.
- Braver Wealth Management bought 84 Amgen shares in Q4 2016, an estimated $12.6K.
- Amgen made up 0.57% of Braver Wealth Management's portfolio in Q4 2016, its #53 holding.
- Braver Wealth Management first reported a position in Amgen in Q1 2014 and has held it in 12 quarters since.
- Braver Wealth Management's Amgen position peaked at $4.83M in Q1 2016.
- 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.
Based on Braver Wealth Management's 13F filing for Q4 2016, filed 14 Feb 2017.